Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. [electronic resource]
Producer: 19991122Description: 2620-8 p. digitalISSN:- 1078-0432
- ATP-Binding Cassette Transporters -- biosynthesis
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Renal Cell -- drug therapy
- Cisplatin -- administration & dosage
- Dihydrouracil Dehydrogenase (NADP)
- Dose-Response Relationship, Drug
- Drug Resistance, Multiple -- genetics
- Drug Resistance, Neoplasm -- genetics
- Drug Synergism
- Fluorouracil -- administration & dosage
- Gastrointestinal Neoplasms -- drug therapy
- Gene Expression Regulation, Neoplastic -- drug effects
- Glutathione S-Transferase pi
- Glutathione Transferase -- biosynthesis
- Humans
- Isoenzymes -- biosynthesis
- K562 Cells -- drug effects
- Kidney Neoplasms -- drug therapy
- Multidrug Resistance-Associated Proteins
- Neoplasm Proteins -- biosynthesis
- Oxidoreductases -- biosynthesis
- Thymidylate Synthase -- genetics
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.